Navigating the New Terrain Patent Strategy Amidst Legal Changes in 2025
L'événement s'est terminé

Navigating the New Terrain Patent Strategy Amidst Legal Changes in 2025

Par UCSF Rosenman Institute
Événement en ligne
8 mai à 20 UTC
Overview

Speaker: Tamara Palmer, Associate, Brown Rudnick Adam Schoen, Partner, Brown Rudnick

Join us to uncover critical patent law decisions impacting startups and growing businesses. Tailored for startup founders and innovators, this session will equip you to effectively adapt patent strategies amidst the evolving legal landscape.

Key takeaways:

  • Understanding the Shift: Analyze recent patent law decisions.
  • Strategic Adaptation: Modify your patent strategy effectively.
  • Real-World Implications: Practical startup examples.
  • Investor Interactions: Aligning patent strategies with investor expectations.
  • Future-Proofing: Anticipating legal trends to stay competitive.

About the Speakers:


Adam Schoen, Partner, Brown Rudnick

Adam Schoen is a partner in Brown Rudnick’s Global Life Sciences Practice Group with an emphasis on intellectual property. With over a decade of experience advising life sciences and medical device funds, companies and academic institutions, Adam helps his clients build, grow, invest in, buy and sell companies of all sizes all over the world. Adam’s practice is multidisciplinary, encompassing all aspects of patent preparation and prosecution, portfolio development, product clearance, freedom to operate analysis, intellectual property due diligence, licensing and other agreement work.

Adam has experience developing and implementing patent strategies across the life sciences industry, working with therapeutics, biologics, diagnostics, medical device and digital health companies. He works with a variety of technologies, such as small molecule therapeutics, biologics (including immunotherapeutics), next generation sequencing technologies, microfluidics and droplet based technologies, diagnostics (including cancer and fertility diagnostics), medical device technology (ophthalmology, cardiology, orthopedics, neurology, spine), medical imaging technology (IVUS and OCT), mass spectrometry and digital health products. He manages patent portfolios of all sizes and develops strategies to maximize and protect intellectual property rights in both the United States and foreign jurisdictions.

Prior to law school, Adam was a scientist of analytical chemistry for ArQule Inc., a combinatorial chemistry and drug discovery company, and a scientist at Millennium Pharmaceuticals, Inc.

Tamara Palmer, Patent Attorney, Brown Rudnick


Tamara Palmer is an associate at Brown Rudnick’s Intellectual Property Practice Group and a member of the Firm’s Global Life Sciences Group. Tamara’s IP practice focuses on all aspects of patent prosecution, as well as IP due diligence analysis, freedom to operate analysis, product clearance, and helping clients develop their patent portfolio. Tamara’s background as both a chemist and educator supports her advocacy in diverse practice areas encompassing small molecule therapeutics, pharmaceutical formulations, biologics, medical devices, instrumentation, and emerging technologies such as AI and virtual/augmented reality applications. Tamara is a leader in the Firm’s FemTech Initiative which seeks to support companies developing technologies that address women’s unique health and wellness needs and innovations in female-focused markets.

Speaker: Tamara Palmer, Associate, Brown Rudnick Adam Schoen, Partner, Brown Rudnick

Join us to uncover critical patent law decisions impacting startups and growing businesses. Tailored for startup founders and innovators, this session will equip you to effectively adapt patent strategies amidst the evolving legal landscape.

Key takeaways:

  • Understanding the Shift: Analyze recent patent law decisions.
  • Strategic Adaptation: Modify your patent strategy effectively.
  • Real-World Implications: Practical startup examples.
  • Investor Interactions: Aligning patent strategies with investor expectations.
  • Future-Proofing: Anticipating legal trends to stay competitive.

About the Speakers:


Adam Schoen, Partner, Brown Rudnick

Adam Schoen is a partner in Brown Rudnick’s Global Life Sciences Practice Group with an emphasis on intellectual property. With over a decade of experience advising life sciences and medical device funds, companies and academic institutions, Adam helps his clients build, grow, invest in, buy and sell companies of all sizes all over the world. Adam’s practice is multidisciplinary, encompassing all aspects of patent preparation and prosecution, portfolio development, product clearance, freedom to operate analysis, intellectual property due diligence, licensing and other agreement work.

Adam has experience developing and implementing patent strategies across the life sciences industry, working with therapeutics, biologics, diagnostics, medical device and digital health companies. He works with a variety of technologies, such as small molecule therapeutics, biologics (including immunotherapeutics), next generation sequencing technologies, microfluidics and droplet based technologies, diagnostics (including cancer and fertility diagnostics), medical device technology (ophthalmology, cardiology, orthopedics, neurology, spine), medical imaging technology (IVUS and OCT), mass spectrometry and digital health products. He manages patent portfolios of all sizes and develops strategies to maximize and protect intellectual property rights in both the United States and foreign jurisdictions.

Prior to law school, Adam was a scientist of analytical chemistry for ArQule Inc., a combinatorial chemistry and drug discovery company, and a scientist at Millennium Pharmaceuticals, Inc.

Tamara Palmer, Patent Attorney, Brown Rudnick


Tamara Palmer is an associate at Brown Rudnick’s Intellectual Property Practice Group and a member of the Firm’s Global Life Sciences Group. Tamara’s IP practice focuses on all aspects of patent prosecution, as well as IP due diligence analysis, freedom to operate analysis, product clearance, and helping clients develop their patent portfolio. Tamara’s background as both a chemist and educator supports her advocacy in diverse practice areas encompassing small molecule therapeutics, pharmaceutical formulations, biologics, medical devices, instrumentation, and emerging technologies such as AI and virtual/augmented reality applications. Tamara is a leader in the Firm’s FemTech Initiative which seeks to support companies developing technologies that address women’s unique health and wellness needs and innovations in female-focused markets.

Organisé par
UCSF Rosenman Institute
Abonnés--
Événements47
Organisation3 années
Signaler cet événement
Événement terminé